healthy subjects C50.9
Conditions
Interventions
Group 1: -determination of biomarkers (ncRNAs) from urine of women with breast cancer.
-This requires a one-time urine collection from the patients.
Group 2: -determination of biomarkers (ncRNAs) fr
Sponsors
Prof. Dr. Thalia ErbesUniversitätsklinikum FreiburgKlinik für Frauenheilkunde
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: patients: Confirmed diagnosis of a primary, non pretreated breast cancer - female sex - signed declaration of consent - >18 years old Comparison test subjects: - >18 years old - female sex - signed declaration of consent
Exclusion criteria
Exclusion criteria: Age: <18 years - Condition after breast cancer disease - Pregnancy - Acute infections Participation in a drug study within the last 3 months (exclusion by corresponding passage in the declaration of consent)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determination of the precision of the developed non-invasive diagnostic procedure. endpoint: sensitivity, specificity relative to the reference (biopsy for tumor resection) | — |
Secondary
| Measure | Time frame |
|---|---|
| Determination of the significance of the developed non-invasive diagnostic procedure for the analyzed population. endpoint: positive predictive value, negative predictive value. | — |
Countries
Germany
Contacts
Public ContactDaniela Weiß
Klinikum für FrauenheilkundeUniversitätsklinikum Freiburg
Outcome results
None listed